Anti-Aging & Longevity

Epitalon

Epithalon · Ala-Glu-Asp-Gly · synthetic pineal peptide

research popular subQ injection / nasal

What it is

Epitalon is a synthetic four-amino-acid peptide developed in Russia in the 1980s by Professor Vladimir Khavinson. It's modeled on a natural extract from the pineal gland called Epithalamin. Russian researchers have run multi-decade clinical trials on it — the longest peptide-longevity studies anywhere — reporting reduced all-cause mortality in elderly subjects.

How it works

Epitalon's most discussed mechanism is activating telomerase, the enzyme that maintains telomeres (the protective caps on the ends of your chromosomes). Telomeres shorten with each cell division — when they get too short, cells stop dividing or die. Epitalon appears to lengthen them, at least in cell-culture studies.

Other mechanisms:

Resets melatonin production in the pineal gland — older adults often lose normal melatonin rhythm; Epitalon restores it.
Modulates gene expression — influences several aging-related transcription factors.
Has antioxidant effects — reduces oxidative damage markers.
Improves immune function in older adults via thymic and pineal pathways.

Benefits

Dramatically improved deep sleep quality
Restored melatonin rhythm in older users
Telomere length extension (cell-culture and limited human evidence)
Improved skin quality and elasticity
Enhanced immune function
Reduced markers of biological aging
In Russian trials: reduced all-cause mortality in elderly cohorts (over 12–15 years)
Some users report improved vision (retinitis pigmentosa trial showed 90% positive response)

Timeline

Day 1–3: Most users notice deeper sleep almost immediately.
Week 1–2: Improved morning energy, mood, recovery.
Week 2–3: End of typical dose cycle. Skin clarity may improve.
3–6 months later: Long-tail effects (telomere, biological age) compound with repeated cycles per year.

Dosing & titration

Standard dose5–10 mg subQ daily

Cycle length10–20 days, then off for 4–6 months

Frequency1–3 cycles per year — this is NOT a daily-forever peptide

TimingEvening dosing aligns with natural pineal/melatonin rhythm

Russian protocol10 mg/day for 10 days, repeated 2–3x per year

When to titrate upAlmost never. The protocol is more about cycle length than escalating dose. If 5 mg works, stay there.

Side effects & risks

Vivid dreams (common, often welcome)
Mild sleepiness shortly after evening dose
Injection site reactions
Some users report transient headaches in first few days

Cancer caution: Telomere extension is a double-edged sword. Cancer cells use the same telomerase machinery to become "immortal." Epitalon should NOT be used by anyone with active cancer or recent cancer history. The 2025 study showed Epitalon also extends telomeres in cancer cells via the ALT pathway, which is concerning. Consult an oncologist before any use if cancer history exists.

Typical price

$80–$150 per cycle 10–50 mg from a 503A compounding pharmacy. Because it's only run 1–3 cycles per year, the annual cost is much lower than peptides used continuously.

Studies

Epitalon increases telomere length in human cell lines through telomerase upregulation or ALT activity (2024) — The most recent mechanism study. Showed dose-dependent telomere extension in normal cells via hTERT, in cancer cells via ALT (raising safety questions). PubMed PubMed, 2024
Epithalon peptide induces telomerase activity and telomere elongation in human somatic cells (2003) — Original demonstration of telomerase activation. PubMed Bulletin of Experimental Biology and Medicine, 2003
Improving Biological Age, Telomere Length, and Cognition: A Case Report — Single-subject report documenting epigenetic age reduction and cognitive improvement. Journal of Restorative Medicine Restorative Medicine, 2022
Khavinson long-term mortality studies (Russian) — Multi-decade Russian trials reporting reduced all-cause mortality in elderly cohorts. Summary in: Epitalon (Wikipedia) St. Petersburg Institute of Bioregulation and Gerontology

Educational reference only. Not medical advice. Epitalon is not FDA-approved — the bulk of clinical evidence comes from Russian researchers. Long-term Western trials are still pending.